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Bacterial Infection in Scarring Trachoma
Victor H. Hu,1,2 Patrick Massae,2 Helen A. Weiss,3 Caroline Chevallier,4,5
Jecinta J. Onyango,5 Isaac A. Afwamba,5 David C. W. Mabey,6 Robin L. Bailey,6
and Matthew J. Burton1,2
PURPOSE. To assess whether non-chlamydial bacterial infection
is associated with trachomatous scarring in adults.
METHODS. This was a case–control study of 360 cases with
trachomatous scarring but without trichiasis, and 360 controls
without scarring. All participants underwent clinical examina-
tion, and a swab was taken from the inferior conjunctival
fornix. Samples were inoculated onto blood and chocolate agar
later that day.
RESULTS. Bacterial isolates were identified in 54.0% of cases
compared with 34.6% of controls (P  0.001). A multivariate
logistic regression model adjusted for age and lack of education
showed that scarring was associated with the presence of
commensal organisms (odds ratio [OR], 1.46; 95% confidence
interval [CI], 1.01–2.09) and was strongly associated with the
presence of pathogenic organisms (OR, 4.08; 95% CI, 1.59–
10.45). There was an increasing prevalence of all bacterial
isolates with increasing severity of scarring (Ptrend  0.001).
CONCLUSIONS. Trachomatous scarring is strongly associated with
non-chlamydial bacterial infection compared with controls.
The role of such infection with regard to scarring progression
should be investigated and may have important implications
for trachoma control strategies and prevention of blindness.
(Invest Ophthalmol Vis Sci. 2011;52:2181–2186) DOI:
10.1167/iovs.10-5829
Trachoma is the leading infectious cause of blindness world-wide. It is caused by infection with Chlamydia trachoma-
tis and is characterized by inflammatory changes in the con-
junctiva in children with subsequent conjunctival scarring,
trichiasis, and blinding corneal opacity in adults. It is estimated
that more than 1.3 million people are blind from the disease,
8.2 million have trichiasis, and 40 million have active dis-
ease.1,2
Over the past 30 years, because of improved living stan-
dards and the implementation of trachoma control strategies,
there has been an encouraging downward trend in the global
prevalence of people with active trachoma.2–5 However, tra-
choma is still a public health problem in more than 50 coun-
tries with high levels of active disease where children are at
future risk of scarring and blindness.5 The number of people
estimated to have trichiasis has shown little decline since 1991,
suggesting that progressive conjunctival scarring can occur
even when there has been a marked reduction in active disease
and C. trachomatis infection and that those who already have
conjunctival scarring are at risk of going on to blinding corneal
opacity caused by trachoma.
While nearly all children in hyperendemic areas suffer
repeated infection with C. trachomatis, it is unclear which
factors drive the scarring process in the conjunctiva, why
only a proportion of scarred subjects subsequently have
trichiasis, and why only a proportion of these become blind.
Severe inflammation and prolonged chlamydial infection ap-
pear to put children at increased risk of future scarring.6,7
However, infection with Chlamydia trachomatis is only
rarely found in adults, suggesting that this is not necessarily
the only factor driving progressive scarring.8 –11 While the
onset of trichiasis may be associated with chlamydial infec-
tion,12 incident trichiasis has also been found to develop in
a significant proportion of eyes in a cohort where the chla-
mydial infection rate was 1%.12,13
Chronic conjunctival inflammation is probably a key factor
in the development of blinding trachoma.6,7,13–15 An important
element in maintaining this inflammatory state may be non-
chlamydial bacterial infection. Previous studies have shown
that (non-chlamydial) bacterial infection is found more fre-
quently in patients with trichiasis and is associated with trichi-
asis recurrence after surgery.8,10,15 Patients with trachomatous
conjunctival scarring without trichiasis were also found to
have an increased frequency of bacterial infection compared
with controls, although this was not statistically significant,
probably due to a limited sample size.10 A recent study exam-
ining trichiasis patients 1 year after surgery found that, after
adjustment for other factors, bacterial infection was signifi-
cantly associated with elevated levels of interleukin-1, matrix
metalloproteinase-9, and the ratio of matrix metalloproteinase-
1/tissue inhibitor metalloproteinase-1.16 This finding suggests that
bacterial infection may promote a proinflammatory and tissue
remodelling response in the conjunctiva, possibly through innate
immune mechanisms, which may be an important factor in the
pathogenesis of trachomatous scarring and blindness.
The purpose of this study was to compare the frequency
and type of non-chlamydial bacterial conjunctival infection
between subjects with trachomatous scarring and controls. A
strengthened understanding of the pathophysiology of tracho-
matous scarring and its progression will help in the assessment
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of current blindness prevention strategies and assist in the
development of new interventions.
METHODS
Ethical Approval
This study adhered to the tenets of the Declaration of Helsinki. It was
approved by the Tanzanian National Institute of Medical Research
Ethics Committee, the Kilimanjaro Christian Medical Centre Ethics
Committee and the London School of Hygiene and Tropical Medicine
Ethics Committee. The study was explained to potential study subjects
and written, informed consent was obtained before enrollment.
Subject Recruitment
This study was conducted in the Siha district of the Kilimanjaro region
of northern Tanzania, in what was historically a single village. Two
years before the study the area was divided into three administrative
units, but these still form a single continuous geographic entity. Pre-
vious surveys of children in this village showed a moderate level of
active trachoma. A survey conducted 6 months before the start of this
study found a follicular trachoma (TF) prevalence rate of 18% among 1-
to 9-year-olds. However, no children of the 43 randomly selected
individuals from this village were positive for chlamydia infection by
PCR (Amplicor; Roche Molecular Diagnostics, Mannheim, Germany)
(Courtright P, personal communication, October 2010). A two-stage
process was undertaken to identify suitable candidates for a case-
control study. Initially, a census was made of the resident adult pop-
ulation (18 years or older). At the time of the enumeration, door-to-
door visits were conducted, and available adults were screened for the
presence of trachomatous conjunctival scarring. After participants
with trichiasis or previous eyelid surgery were excluded, individuals
with scarring were invited to join a related cohort study. Only those
with more than minimal scarring (grade S1b or worse, see below) were
included in the analysis of this case-control study. An equal number of
village residents without scarring were invited to join as control sub-
jects, frequency matched by ethnicity.
Clinical Examination
All subjects were examined by an ophthalmologist (VH) using 2.5
loupes and a bright torch. Examinations were performed in a dark tent,
ensuring standard conditions. The 1981 World Health Organization
trachoma grading system3 was used with some modification. The WHO
system for grading conjunctival scarring does not have very objective
definitions for “mild” or “moderate” scarring. Therefore, we developed
a modified system for classifying tarsal conjunctival scarring (Table 1;
example photographs shown in Supplementary Fig. S1, http://www.
iovs.org/lookup/suppl/doi:10.1167/iovs.10-5829/-/DCSupplemental).
Microbiology Samples and Analysis
The conjunctiva was anesthetized with preservative-free proxymeta-
caine 0.5% eye drops (Minims; Chauvin Pharmaceuticals, Montpellier,
France). A rayon-tipped swab sample was collected from the inferior
fornix and placed immediately into Amies charcoal transport medium
(Sterilin, Caerphilly, UK) and kept at ambient temperature. Samples
were inoculated onto blood and chocolate agar later the same day
(rarely 6 hours, usually 5 hours from collection time) and incu-
bated at 37°C for 48 hours. Culture isolates were identified by standard
microbiologic techniques.
Sample Size and Data Analysis
This study was part of a larger series of related studies on the patho-
genesis of trachomatous scarring with the sample size calculated to
encompass these other components. The sample of 360 cases and 360
controls has90% power to detect an association with non-chlamydial
bacterial infection with an odds ratio of 2.5 when such infection is
present in 6%10 of control subjects.
Data were entered into a database (Access 2007; Microsoft, Red-
mond, WA) and analyzed (Stata 10.0; StataCorp LP, College Station,
TX). The 2 test was used to determine strength of association for
individual bacterial isolates or groups of isolates (commensal or patho-
genic organisms) according to case-control status. A nonparametric
test for trend was used to look at prevalence of bacterial culture by the
ordered categories of scarring severity. Given the known association of
trachomatous scarring with age, logistic regression models were used
to estimate single-factor, age-adjusted, odds ratios (ORs) and 95% con-
fidence intervals (CIs) for factors associated with the presence of
scarring and inflammation. A multivariable logistic regression model
was fitted, including age as an a priori factor, and other factors, if they
were associated with scarring in the age-adjusted analysis and indepen-
dently associated in the multivariable model (P 0.1). Likelihood ratio
tests were used to assess the strength of association of each factor with
the outcome, and tests for nonlinearity were conducted to assess
whether fitting age as a continuous variable provided an adequate fit to
the data.
RESULTS
This village had an adult population of 3626 people at the time
of the census, of whom 2418 (67%) were seen. Of those not
seen, 711 (19.6%) were absent at the time of the census,
despite two visits; 347 (9.6%) were temporarily resident else-
where; and 150 (4.1%) refused examination. We excluded 36
(1.0%) due to the presence of trichiasis, previous eyelid sur-
gery, or an inability to give informed consent. Of the remain-
ing, 862 (23.8%) had trachomatous conjunctival scarring, and
1520 (41.9%) did not have scarring.
We recruited 360 cases with trachomatous conjunctival
scarring and 360 control subjects without scarring. Baseline
demographic characteristics are shown in Table 2. The major-
ity of cases and controls were of Maasai ethnicity (77% of both
groups) followed by Chagga ethnicity (11% of both groups).
The controls were younger than the entire census population
(mean age, 31.9 vs. 37.4 years; P 0.001), which may cause an
overestimation of the association of scarring with age in the
study population. Odds of trachomatous scarring increased
twofold with each 10-year increase in age (P  0.001). After
adjustment for age, lack of education was strongly associated
with scarring.
Clinical findings are shown in Table 2. The scarring was
mostly mild to moderate. Conjunctival inflammation (grades P2
and P3) was present in 25.5% of cases and in none of the
controls. Follicles were found very infrequently in both cases
(1.5%) and controls (0.3%).
Bacterial isolates were identified in 54% of cases, compared
with 34% of controls (P  0.001; Table 3). Coagulase negative
TABLE 1. Tarsal Conjunctival Scarring Grading System
Grade Definition*
S1 Scarring occupying 1/3 of the upper lid
S1a One or more pinpoint scars and/or a single line of scarring
less than 2 mm in length†
S1b Multiples lines of scarring less than 2 mm in length
S1c One or more lines/patches of scarring each 2 mm or more
in length/maximal dimension
S2 Patches of scarring occupying in surface area 1/3 but
2/3 of the upper lid
3 Patches of scarring occupying in surface area 2/3 of the
upper lid
* Upper lid, zones 2 and 3 of the everted upper lid.3
† 2 mm was chosen, as this is the approximate width of the lower
lid margin, which is readily available for comparison.
2182 Hu et al. IOVS, April 2011, Vol. 52, No. 5
staphylococci (CNS), Corynebacterium spp., Streptococcus
viridans, and Bacillus spp. were designated as commensal
organisms for the purposes of this analysis. Both pathogenic
and commensal organisms were more prevalent in cases versus
controls (pathogenic: 6.7% vs. 1.9%; OR, 4.90; 95% CI, 2.06–
11.65; P  0.001; commensal: 47.4% vs. 32.6%; OR, 2.09; 95%
CI, 1.54–2.84; P  0.001). There was an increasing prevalence
of bacterial isolates (both commensal and pathogenic), with
increasing severity of scarring (Ptrend  0.001, Table 4).
To assess the association between papillary inflammation
and bacterial isolates among those with scarring, the cases
were subdivided into either inflamed (P2 or P3) or nonin-
flamed (P0 or P1). There were 92 (25.6%) inflamed cases and
268 (74.4%) noninflamed cases. A bacterial isolate (commensal
or pathogenic) was cultured in 60 (65.2%) of the inflamed
cases compared with 135 (50.4%) of the noninflamed cases
(OR, 1.86; 95% CI, 1.14–3.04; P  0.01). Commensal organ-
isms were not significantly associated with inflammation, being
found in 45 (48.9%) of the inflamed cases and 126 (47.0%) of
the noninflamed ones (OR, 1.48; 95% CI, 0.89–2.48; P 0.13).
There was no evidence that individual commensal organisms
were associated with inflammation. The presence of patho-
genic organisms, however, was strongly associated with in-
flammation. They were detected in 15 (16.3%) of 92 of in-
flamed cases and 9 (3.4%) of 268 of the noninflamed (OR, 6.93;
95% CI, 2.79–17.24; P  0.001).
Multivariable analyses showed that trachomatous scarring
was independently associated with increasing age and lack of
education (Table 5). Scarring was also associated with the
presence of commensal organisms (adjusted OR, 1.47; 95% CI,
1.03–2.12) and was strongly associated with pathogenic organ-
isms (adjusted OR, 4.08; 95% CI, 1.60–10.43).
DISCUSSION
This study showed, for the first time, that trachomatous scar-
ring without trichiasis is strongly associated with non-chlamyd-
ial bacterial infection in cases compared with controls. Chla-
mydial infection itself is only rarely found in adults with
scarring, and repeated infectious episodes with other bacteria
may contribute to progressive scarring.
Several studies from The Gambia have examined the role of
bacterial infection and inflammation in cicatricial trachoma,
although most of these have been in patients with trichiasis.
Bacterial infection was found before surgery in 30% of patients
undergoing trichiasis surgery. Recurrent trichiasis at 12 months
was associated with conjunctival inflammation and bacterial
TABLE 2. Demographic and Clinical Characteristics of the Study Participants and Age-Adjusted Associations with Scarring
Cases (n  360) Controls (n  360) Age-Adjusted Association with Scarring
Parameter n (%) n (%) OR 95% CI P
Age groups, y 0.001
18–25 29 (8.1) 117 (32.5) 1
25–35 53 (14.7) 113 (31.4) 1.88 1.11–3.16
35–45 65 (18.1) 85 (23.6) 3.13 1.87–5.26
45–55 80 (22.2) 28 (7.8) 11.53 6.38–20.84
55–65 57 (15.8) 9 (2.5) 28.75 12.36–66.87
65 76 (21.1) 8 (2.2) 34.07 15.28–75.95
Age in years, mean (95% CI) 50.2 (48.3–2.0) 31.9 (30.7–3.1) Trend 2.19* (1.92–2.49) 0.001
Sex 0.40
Female 219 (60.8) 241 (66.9) 1.00 —
Male 141 (39.2) 119 (33.1) 1.17 0.81–1.68
Formal education† 0.001
None 250 (69.4) 166 (46.1) 1.00 —
1–7 y 106 (29.4) 177 (49.2) 0.61 0.42–0.87
7 y 4 (1.1) 17 (4.7) 0.24 0.06–0.86
BMI‡ 0.55
Underweight 55 (15.4) 30 (8.5) 1.35 0.77–2.39
Normal 257 (72.0) 284 (80.0) 1.00 —
Overweight/obese 45 (12.6) 41 (11.6) 1.12 0.66–1.89
Scarring grade§
0 — — 360 (100)
1a 0 (0.0) — —
1b 187 (51.9) — —
1c 127 (35.3) — —
2 33 (9.2) — —
3 13 (3.6) — —
Papillary inflammation grade
P0 80 (22.2) 343 (95.3)
P1 188 (52.2) 17 (4.7)
P2 84 (23.3) 0 (0.0)
P3 8 (2.2) 0 (0.0)
Follicles
F0 355 (98.6) 359 (99.7)
F1 2 (0.6) 1 (0.3)
F2 1 (0.3) 0 (0.0)
F3 2 (0.6) 0 (0.0)
* The result shown is the increase in the OR with each increase in age group category.
† Primary schooling in Tanzania is completed after 7 years.
‡ Categories from the National Institutes of Health.
§ All controls had no scarring (grade 0), and all cases had scarring grade 1b or higher.
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infection at 12 months.8 Postoperative bacterial infection and
conjunctival inflammation were also associated with recurrent
trichiasis in another study in which examined patients were
examined 3.5 years after surgery.8,15 Bacterial infection and
inflammation were found to be associated with major trichiasis
(five or more lashes touching the globe) in a cohort study of
Gambian patients with trichiasis who declined surgery; how-
ever, neither was significantly associated with progression in
trichiasis after adjustment for other factors.13 Finally, the first
of two related case-control studies found that patients with
trichiasis had an increased bacterial infection rate compared
with controls and that infection was more common with in-
creasing trichiasis severity.10 In the second case-control study,
while there was an increased infection rate in those with
trachomatous scarring without trichiasis, this did not reach
statistical significance (OR, 2.2; 95% CI 0.79–6.33; P  0.144),
probably because of a limited sample size. The current study,
which has greater power, showed that scarring is associated
with bacterial infection. Several clinical trials have investigated
the effect of single-dose oral azithromycin after trichiasis sur-
gery on TT recurrence. These have reported variable impact on
the subsequent recurrence rate. It is plausible that at least part
of the benefit of this intervention is attributable to the effect of
this antibiotic on Gram-positive infection rather than on chla-
mydial infection alone.8,17,18
The results of studies on patients with trichiasis cannot
necessarily be extrapolated to those with scarring alone, as the
two groups are notably different. Trichiasis denotes lashes
rubbing against the globe, causing mechanical damage and a
persistent foreign body on the ocular surface. This effect pro-
vides a nidus for infection that may itself lead to an increased
risk of infection and inflammation rather than the other way
around. In this study we found that scarring without trichiasis
is also associated with bacterial infection and inflammation.
While cause and effect cannot be established with this study,
we are currently observing a cohort of scarred subjects who
are being assessed at regular intervals for infection and scarring
progression.
Earlier studies have also examined bacterial culture rates in
active trachoma, especially in relation to seasonal epidemics of
TABLE 4. Bacterial Culture Rates by Scarring Grade
Conjunctival Scarring Grade
Test for
Trend
P
0 (n  360) 1b (n  187) 1c (n  127) 2 (n  33) 3 (n  13)
n (%) n (%) n (%) n (%) n (%)
Any isolate cultured 124 (34.4) 84 (44.9) 78 (61.4) 23 (69.7) 10 (76.9) 0.001
Type of isolate cultured
None 236 (65.6) 103 (55.1) 49 (38.6) 10 (30.3) 3 (23.1)
Commensal only 117 (32.5) 76 (40.6) 68 (53.5) 18 (54.6) 9 (69.2) 0.001
Pathogenic / commensal 7 (1.9) 8 (4.3) 10 (7.9) 5 (15.2) 1 (7.7) 0.001
TABLE 3. Bacterial Culture Results by Case-Control Status
Cases (n  360) Controls (n  360)
n (%) n (%) 2 test
Any isolate cultured 195 (54.2) 124 (34.4) 0.001
Number of organisms cultured
0 165 (45.8) 236 (65.6) —
1 125 (34.7) 96 (26.7) 0.001
2 66 (18.3) 24 (6.7) 0.001
3 4 (1.1) 4 (1.1) 0.62
Type of isolate cultured*
None 165 (45.8) 236 (65.6) —
Commensal only 171 (47.5) 117 (32.5) 0.001
Pathogenic / commensal 24 (6.7) 7 (1.9) 0.001
Organisms
CNS 110 (30.6) 69 (19.2) 0.001
Corynebacterium spp. 89 (24.7) 42 (11.7) 0.001
Viridans group streptococci 35 (9.7) 32 (8.9) 0.70
Bacillus spp. 8 (2.2) 8 (2.2) 1.0
Haemophilus influenzae, B 9 (2.5) 0 (0.0) 0.003
Streptococcus pneumoniae 7 (1.9) 1 (0.3) 0.03
Escherichia coli 3 (0.8) 0 (0.0) 0.08
Neisseria spp. 3 (0.8) 0 (0.0) 0.08
Staphylococcus aureus 2 (0.6) 0 (0.0) 0.16
Aeromonas hydrophilia 0 (0.0) 2 (0.6) 0.16
Fungus, mould 0 (0.0) 2 (0.6) 0.16
Gram negative rods (other) 1 (0.3) 1 (0.3) 1.0
Actinomyces 1 (0.3) 0 (0.0) 0.32
Enterobacter cloacae 1 (0.3) 0 (0.0) 0.32
Gram-negative rods, non-Lactose fermenting 1 (0.3) 0 (0.0) 0.32
Klebsiella spp. 0 (0.0) 1 (0.3) 0.32
* Commensal organisms include CNS, Corynebacterium spp., and Viridans group streptococci.
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bacterial conjunctivitis.19–25 However, most of these studies
were in children without cicatricial stages of trachoma, did not
contain control groups, and used older trachoma grading sys-
tems that are difficult to compare with those currently used.
The two studies that did compare groups with and without
trachoma showed little difference in the bacterial isolation
rates between the two groups; however, these findings relate
only to children with active disease.24,25
Monkey models of trachoma have also sought to elucidate
the relationship between trachoma and bacterial infection.
These have shown that bacterial co-infection in active disease
did not result in more severe disease.26 However, when bac-
teria were introduced into eyes with conjunctival scarring, a
more marked and prolonged inflammatory reaction was pro-
duced compared with control animals.26
Another interesting question that our study raises is the role
and definition of commensal organisms. Such organisms can
act as part of the defensive mechanism of the ocular surface by
preventing colonization and infection by more pathogenic bac-
teria.27 However, deciding which organisms to categorize as a
commensal can be a moot point. Previous studies have gone
some way toward identifying organisms commonly found on
the ocular surface of healthy eyes which generally behave in a
non-pathogenic manner. These include CNS and Corynebacte-
ria.28–32 However, findings depend on various factors. Poly-
merase chain reaction with DNA sequencing, for example,
detects a much broader range and higher frequency of organ-
isms than does conventional bacterial culture.31 The popula-
tion being sampled is important, as many studies performed so
far have been on subjects from developed areas. A recent
survey from Sierra Leone of healthy eyes found a much higher
proportion of isolates of bacteria usually thought of as patho-
genic than previous studies, as well as fungi, the significance of
which remains unknown.32
We found that one third of our control subjects had an
organism cultured. This is on the lower end of the range
compared with results of previous studies on the conjunctival
flora, which showed culture rates of between 34% and
100%.28–32 This discrepancy may be partly because our study
was conducted in a remote, rural community and there was a
short delay in getting the samples to the laboratory. However,
the sample handling was identical between cases and controls,
and we do not believe that any systematic bias resulted. We
considered any increase in detection rates that may be
achieved with plating the swabs directly onto culture media in
the field would have been outweighed by higher contamina-
tion rates.
We included Streptococcus viridans and Bacillus as com-
mensal organisms as well as CNS and Corynebacteria. S. viri-
dans is a common oral commensal which is also frequently
found in the ocular flora in trachoma endemic areas and does
not appear to act in a pathogenic manner.20,23,24 Poor dental
hygiene in these areas may facilitate spread of the organism
from the oral cavity to the eye, which are joined by a contin-
uous mucosal surface. Bacillus was also included as a commen-
sal organism, as a number of factors indicated that it was acting
in a nonpathogenic manner. It was found equally in cases and
controls; on all the occasions on which it was cultured, there
was only mild growth and there was usually co-culture with
other organisms; and it did not cause any clinically significant
inflammation.
In our study, pathogens were significantly associated with
inflammation while commensals (both individually and overall)
were not. This result suggests that the scarred surface is more
easily colonized by commensal organisms with little adverse
effect, although a subclinical effect cannot be ruled out. The
scarred surface also appears to be more prone to infection with
pathogens that do cause inflammation and, perhaps, scarring
progression.
Our study benefited from a prospective approach with
standard clinical grading. There was minimal delay between
taking the swabs and inoculating samples onto the culture
medium. We also identified and adjusted for potential con-
founding factors. A potential confounder was the difference in
age between cases and controls; however, bacterial infection
remained significantly associated with scarring even after ad-
justment for age in a logistic regression model. Limitations of
the study include not having a specific culture for fungi, which
may have led to underestimation of their role. This study was
conducted in an area mesoendemic for trachoma, and the level
of scarring in the cases reflected this, being relatively mild,
with most of the cases having less than one third of the upper
lid scarred. This study, therefore, is applicable to the many
other areas with a moderate level of trachoma. We found that
the infection rate tended to increase with the level of scarring,
suggesting that more bacterial infection would be found in
communities with more severe scarring.
Chlamydial infection data are not available for this group of
subjects. However, in this setting, we would expect the prev-
alence of infection with C. trachomatis in adults to be low,
previous studies having suggested it the would probably be
between 0% and 10%.8–13
In summary, trachomatous conjunctival scarring is associ-
ated with increased bacterial infection, the role of which war-
rants further investigation, especially with regard to scarring
progression and the risk of blindness.
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